Cyclosporin/NN
A/NN
inhibits/VBZ
monocyte/NN
tissue/NN
factor/NN
activation/NN
in/IN
cardiac/JJ
transplant/NN
recipients/NNS
./.

BACKGROUND/NN
:/:
Fibrin/NN
deposition/NN
and/CC
thrombosis/NN
have/VBP
been/VBN
implicated/VBN
in/IN
both/CC
allograft/NN
rejection/NN
and/CC
vasculopathy/NN
after/IN
cardiac/JJ
transplantation/NN
./.
=====
Because/IN
monocytes/NNS
play/VBP
a/DT
pivotal/JJ
role/NN
in/IN
the/DT
pathophysiology/NN
of/IN
intravascular/JJ
coagulation/NN
activation/NN
through/IN
their/PRP$
ability/NN
to/TO
synthesize/VB
tissue/NN
factor/NN
(/(
TF/NN
)/)
,/,
we/PRP
asked/VBD
(/(
1/LS
)/)
whether/IN
monocyte/NN
TF/NN
activation/NN
occurs/VBZ
in/IN
cardiac/JJ
transplant/NN
recipients/NNS
and/CC
(/(
2/LS
)/)
whether/IN
monocyte/NN
TF/NN
expression/NN
is/VBZ
affected/VBN
by/IN
treatment/NN
with/IN
cyclosporin/NN
A/NN
(/(
CsA/NN
)/)
./.
=====
METHODS/NNS
AND/CC
RESULTS/NNS
:/:
We/PRP
measured/VBD
levels/NNS
of/IN
TF/NN
activity/NN
in/IN
peripheral/JJ
blood/NN
mononuclear/JJ
cells/NNS
and/CC
highly/RB
purified/VBN
monocytes/macrophages/NNS
from/IN
10/CD
consecutive/JJ
cardiac/JJ
transplant/NN
recipients/NNS
and/CC
10/CD
healthy/JJ
control/JJ
subjects/NNS
./.
=====
TF/NN
activity/NN
generated/VBN
by/IN
both/CC
unstimulated/JJ
and/CC
endotoxin-stimulated/JJ
cells/NNS
was/VBD
significantly/RB
higher/JJR
in/IN
transplant/NN
recipients/NNS
than/IN
in/IN
control/JJ
subjects/NNS
(/(
P/NN
</JJR
.05/CD
)/)
./.
=====
Increased/VBN
monocyte/NN
TF/NN
expression/NN
in/IN
transplant/NN
recipients/NNS
was/VBD
shown/VBN
to/TO
be/VB
adversely/RB
affected/VBN
by/IN
treatment/NN
with/IN
CsA/NN
:/:
TF/NN
induction/NN
was/VBD
markedly/RB
reduced/VBN
by/IN
CsA/NN
serum/NN
concentrations/NNS
reaching/VBG
peak/JJ
CsA/NN
drug/NN
levels/NNS
./.
=====
Inhibition/NN
of/IN
TF/NN
induction/NN
in/IN
the/DT
presence/NN
of/IN
high/JJ
CsA/NN
blood/NN
concentrations/NNS
was/VBD
also/RB
observed/VBN
when/WRB
stimulation/NN
of/IN
cells/NNS
was/VBD
performed/VBN
with/IN
interferon-gamma/NN
or/CC
interleukin-1beta/NN
./.
=====
As/IN
shown/VBN
by/IN
reverse/JJ
transcription-polymerase/NN
chain/NN
reaction/NN
and/CC
electrophoretic/JJ
mobility/NN
shift/NN
assay/NN
,/,
respectively/RB
,/,
treatment/NN
with/IN
CsA/NN
leads/VBZ
to/TO
decreased/VBN
TF/NN
mRNA/NN
expression/NN
and/CC
reduced/VBN
activation/NN
of/IN
the/DT
NF-kappaB/NN
transcription/NN
factor/NN
,/,
which/WDT
is/VBZ
known/VBN
to/TO
contribute/VB
to/TO
the/DT
induction/NN
of/IN
the/DT
TF/NN
promotor/NN
in/IN
human/JJ
monocytes/NNS
./.
=====
CONCLUSIONS/NNS
:/:
This/DT
study/NN
demonstrates/VBZ
that/IN
TF/NN
activation/NN
,/,
occurring/VBG
in/IN
mononuclear/JJ
cells/NNS
of/IN
cardiac/JJ
transplant/NN
recipients/NNS
,/,
is/VBZ
inhibited/VBN
by/IN
treatment/NN
with/IN
CsA/NN
./.
=====
Inhibition/NN
of/IN
monocyte/NN
TF/NN
induction/NN
by/IN
CsA/NN
may/MD
contribute/VB
to/TO
its/PRP$
successful/JJ
use/NN
in/IN
cardiac/JJ
transplant/NN
medicine/NN
and/CC
might/MD
be/VB
useful/JJ
in/IN
managing/VBG
further/JJ
settings/NNS
of/IN
vascular/JJ
pathology/NN
also/RB
known/VBN
to/TO
involve/VB
TF/NN
expression/NN
and/CC
NF-kappaB/NN
activation/NN
./.